Imidazole derivatives used as TAFIa inhibitors

Details for Australian Patent Application No. 2005238144 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Heitsch, Holger; Grueneberg, Sven; Lindenschmidt, Andreas; Kallus, Christopher

Agent Watermark

Pub. Number AU-B-2005238144

PCT Pub. Number WO2005/105781

Priority 10 2004 020 186.2 22.04.04 DE

Filing date 7 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 26 August 2010

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105781 Priority application(s): WO2005/105781

26 August 2010 Application Accepted

  Published as AU-B-2005238144

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238149-Process and plant for producing sulfuric acid from gases rich in sulfur dioxide

2005238143-Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof